GGRNA Home | Help | Advanced search

2024-03-28 20:01:55, GGRNA : RefSeq release 60 (20130726)

LOCUS       NM_001079670            3538 bp    mRNA    linear   PRI 16-JUN-2013
DEFINITION  Homo sapiens calcium binding protein 39-like (CAB39L), transcript
            variant 2, mRNA.
ACCESSION   NM_001079670
VERSION     NM_001079670.1  GI:118766334
KEYWORDS    RefSeq.
SOURCE      Homo sapiens (human)
  ORGANISM  Homo sapiens
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
            Catarrhini; Hominidae; Homo.
REFERENCE   1  (bases 1 to 3538)
  AUTHORS   Zhang,W.J., Zhang,W.G., Zhang,P.Y., Cao,X.M., He,A.L., Chen,Y.X.
            and Gu,L.F.
  TITLE     The expression and functional characterization associated with cell
            apoptosis and proteomic analysis of the novel gene MLAA-34 in U937
            cells
  JOURNAL   Oncol. Rep. 29 (2), 491-506 (2013)
   PUBMED   23135622
  REMARK    GeneRIF: In conclusion, our current results provide new evidence
            that MLAA-34 may be a novel anti-apoptotic factor in vitro, and the
            data presented here show a strong correlation between
            anti-apoptosis with the upregulation of MLAA-34.
REFERENCE   2  (bases 1 to 3538)
  AUTHORS   Zhao,J., He,A., Zhang,W., Meng,X. and Gu,L.
  TITLE     Quantitative assessment of MLAA-34 expression in diagnosis and
            prognosis of acute monocytic leukemia
  JOURNAL   Cancer Immunol. Immunother. 60 (4), 587-597 (2011)
   PUBMED   21240483
  REMARK    GeneRIF: our data indicate that MLAA-34 may be used as a prognostic
            marker for treatment decision-making in acute monocytic leukemia
REFERENCE   3  (bases 1 to 3538)
  AUTHORS   Zhang,P.Y., Zhang,W.G., He,A.L., Wang,J.L. and Li,W.B.
  TITLE     Identification and functional characterization of the novel acute
            monocytic leukemia associated antigen MLAA-34
  JOURNAL   Cancer Immunol. Immunother. 58 (2), 281-290 (2009)
   PUBMED   18592235
  REMARK    GeneRIF: It was proposed that a splice variant MLAA-34 of CAB39L
            associated with acute monocytic leukemia.  MLAA-34 was identified
            and characterized.  Identification and functional characterization
            of the novel acute monocytic leukemia associated antigen MLAA-34
REFERENCE   4  (bases 1 to 3538)
  AUTHORS   Kahn,B.B., Alquier,T., Carling,D. and Hardie,D.G.
  TITLE     AMP-activated protein kinase: ancient energy gauge provides clues
            to modern understanding of metabolism
  JOURNAL   Cell Metab. 1 (1), 15-25 (2005)
   PUBMED   16054041
  REMARK    Review article
REFERENCE   5  (bases 1 to 3538)
  AUTHORS   Dunham,A., Matthews,L.H., Burton,J., Ashurst,J.L., Howe,K.L.,
            Ashcroft,K.J., Beare,D.M., Burford,D.C., Hunt,S.E.,
            Griffiths-Jones,S., Jones,M.C., Keenan,S.J., Oliver,K., Scott,C.E.,
            Ainscough,R., Almeida,J.P., Ambrose,K.D., Andrews,D.T.,
            Ashwell,R.I., Babbage,A.K., Bagguley,C.L., Bailey,J., Bannerjee,R.,
            Barlow,K.F., Bates,K., Beasley,H., Bird,C.P., Bray-Allen,S.,
            Brown,A.J., Brown,J.Y., Burrill,W., Carder,C., Carter,N.P.,
            Chapman,J.C., Clamp,M.E., Clark,S.Y., Clarke,G., Clee,C.M.,
            Clegg,S.C., Cobley,V., Collins,J.E., Corby,N., Coville,G.J.,
            Deloukas,P., Dhami,P., Dunham,I., Dunn,M., Earthrowl,M.E.,
            Ellington,A.G., Faulkner,L., Frankish,A.G., Frankland,J.,
            French,L., Garner,P., Garnett,J., Gilbert,J.G., Gilson,C.J.,
            Ghori,J., Grafham,D.V., Gribble,S.M., Griffiths,C., Hall,R.E.,
            Hammond,S., Harley,J.L., Hart,E.A., Heath,P.D., Howden,P.J.,
            Huckle,E.J., Hunt,P.J., Hunt,A.R., Johnson,C., Johnson,D., Kay,M.,
            Kimberley,A.M., King,A., Laird,G.K., Langford,C.J., Lawlor,S.,
            Leongamornlert,D.A., Lloyd,D.M., Lloyd,C., Loveland,J.E.,
            Lovell,J., Martin,S., Mashreghi-Mohammadi,M., McLaren,S.J.,
            McMurray,A., Milne,S., Moore,M.J., Nickerson,T., Palmer,S.A.,
            Pearce,A.V., Peck,A.I., Pelan,S., Phillimore,B., Porter,K.M.,
            Rice,C.M., Searle,S., Sehra,H.K., Shownkeen,R., Skuce,C.D.,
            Smith,M., Steward,C.A., Sycamore,N., Tester,J., Thomas,D.W.,
            Tracey,A., Tromans,A., Tubby,B., Wall,M., Wallis,J.M., West,A.P.,
            Whitehead,S.L., Willey,D.L., Wilming,L., Wray,P.W., Wright,M.W.,
            Young,L., Coulson,A., Durbin,R., Hubbard,T., Sulston,J.E., Beck,S.,
            Bentley,D.R., Rogers,J. and Ross,M.T.
  TITLE     The DNA sequence and analysis of human chromosome 13
  JOURNAL   Nature 428 (6982), 522-528 (2004)
   PUBMED   15057823
REFERENCE   6  (bases 1 to 3538)
  AUTHORS   Lee,S.Y., Obata,Y., Yoshida,M., Stockert,E., Williamson,B.,
            Jungbluth,A.A., Chen,Y.T., Old,L.J. and Scanlan,M.J.
  TITLE     Immunomic analysis of human sarcoma
  JOURNAL   Proc. Natl. Acad. Sci. U.S.A. 100 (5), 2651-2656 (2003)
   PUBMED   12601173
COMMENT     VALIDATED REFSEQ: This record has undergone validation or
            preliminary review. The reference sequence was derived from
            DA146462.1, BX647518.1, AA278473.1, AL138875.8 and CA450475.1.
            
            ##Evidence-Data-START##
            Transcript exon combination :: BX647518.1 [ECO:0000332]
            RNAseq introns              :: mixed/partial sample support
                                           ERS025082 [ECO:0000350]
            ##Evidence-Data-END##
            COMPLETENESS: complete on the 3' end.
PRIMARY     REFSEQ_SPAN         PRIMARY_IDENTIFIER PRIMARY_SPAN        COMP
            1-22                DA146462.1         1-22
            23-619              BX647518.1         1-597
            620-951             AA278473.1         148-479
            952-2375            BX647518.1         930-2353
            2376-2995           AL138875.8         70004-70623         c
            2996-3538           CA450475.1         1-543               c
FEATURES             Location/Qualifiers
     source          1..3538
                     /organism="Homo sapiens"
                     /mol_type="mRNA"
                     /db_xref="taxon:9606"
                     /chromosome="13"
                     /map="13q14.2"
     gene            1..3538
                     /gene="CAB39L"
                     /gene_synonym="bA103J18.3; MO25-BETA; MO2L; RP11-103J18.3"
                     /note="calcium binding protein 39-like"
                     /db_xref="GeneID:81617"
                     /db_xref="HGNC:20290"
                     /db_xref="MIM:612175"
     exon            1..100
                     /gene="CAB39L"
                     /gene_synonym="bA103J18.3; MO25-BETA; MO2L; RP11-103J18.3"
                     /inference="alignment:Splign:1.39.8"
     exon            101..238
                     /gene="CAB39L"
                     /gene_synonym="bA103J18.3; MO25-BETA; MO2L; RP11-103J18.3"
                     /inference="alignment:Splign:1.39.8"
     variation       159
                     /gene="CAB39L"
                     /gene_synonym="bA103J18.3; MO25-BETA; MO2L; RP11-103J18.3"
                     /replace="c"
                     /replace="t"
                     /db_xref="dbSNP:3764090"
     exon            239..314
                     /gene="CAB39L"
                     /gene_synonym="bA103J18.3; MO25-BETA; MO2L; RP11-103J18.3"
                     /inference="alignment:Splign:1.39.8"
     misc_feature    271..273
                     /gene="CAB39L"
                     /gene_synonym="bA103J18.3; MO25-BETA; MO2L; RP11-103J18.3"
                     /note="upstream in-frame stop codon"
     exon            315..456
                     /gene="CAB39L"
                     /gene_synonym="bA103J18.3; MO25-BETA; MO2L; RP11-103J18.3"
                     /inference="alignment:Splign:1.39.8"
     CDS             346..1359
                     /gene="CAB39L"
                     /gene_synonym="bA103J18.3; MO25-BETA; MO2L; RP11-103J18.3"
                     /note="sarcoma antigen NY-SAR-79; antigen MLAA-34;
                     U937-associated antigen; mo25-like protein; MO25beta"
                     /codon_start=1
                     /product="calcium-binding protein 39-like"
                     /protein_id="NP_001073138.1"
                     /db_xref="GI:118766335"
                     /db_xref="CCDS:CCDS9416.2"
                     /db_xref="GeneID:81617"
                     /db_xref="HGNC:20290"
                     /db_xref="MIM:612175"
                     /translation="
MKKMPLFSKSHKNPAEIVKILKDNLAILEKQDKKTDKASEEVSKSLQAMKEILCGTNEKEPPTEAVAQLAQELYSSGLLVTLIADLQLIDFEGKKDVTQIFNNILRRQIGTRSPTVEYISAHPHILFMLLKGYEAPQIALRCGIMLRECIRHEPLAKIILFSNQFRDFFKYVELSTFDIASDAFATFKDLLTRHKVLVADFLEQNYDTIFEDYEKLLQSENYVTKRQSLKLLGELILDRHNFAIMTKYISKPENLKLMMNLLRDKSPNIQFEAFHVFKVFVASPHKTQPIVEILLKNQPKLIEFLSSFQKERTDDEQFADEKNYLIKQIRDLKKTAP
"
     misc_feature    361..1347
                     /gene="CAB39L"
                     /gene_synonym="bA103J18.3; MO25-BETA; MO2L; RP11-103J18.3"
                     /note="Mo25-like; Region: Mo25; pfam08569"
                     /db_xref="CDD:203985"
     exon            457..621
                     /gene="CAB39L"
                     /gene_synonym="bA103J18.3; MO25-BETA; MO2L; RP11-103J18.3"
                     /inference="alignment:Splign:1.39.8"
     exon            622..740
                     /gene="CAB39L"
                     /gene_synonym="bA103J18.3; MO25-BETA; MO2L; RP11-103J18.3"
                     /inference="alignment:Splign:1.39.8"
     variation       623..624
                     /gene="CAB39L"
                     /gene_synonym="bA103J18.3; MO25-BETA; MO2L; RP11-103J18.3"
                     /replace="a"
                     /replace="g"
                     /db_xref="dbSNP:11546263"
     exon            741..909
                     /gene="CAB39L"
                     /gene_synonym="bA103J18.3; MO25-BETA; MO2L; RP11-103J18.3"
                     /inference="alignment:Splign:1.39.8"
     exon            910..969
                     /gene="CAB39L"
                     /gene_synonym="bA103J18.3; MO25-BETA; MO2L; RP11-103J18.3"
                     /inference="alignment:Splign:1.39.8"
     exon            970..1035
                     /gene="CAB39L"
                     /gene_synonym="bA103J18.3; MO25-BETA; MO2L; RP11-103J18.3"
                     /inference="alignment:Splign:1.39.8"
     exon            1036..1179
                     /gene="CAB39L"
                     /gene_synonym="bA103J18.3; MO25-BETA; MO2L; RP11-103J18.3"
                     /inference="alignment:Splign:1.39.8"
     exon            1180..3523
                     /gene="CAB39L"
                     /gene_synonym="bA103J18.3; MO25-BETA; MO2L; RP11-103J18.3"
                     /inference="alignment:Splign:1.39.8"
     STS             1333..1459
                     /gene="CAB39L"
                     /gene_synonym="bA103J18.3; MO25-BETA; MO2L; RP11-103J18.3"
                     /standard_name="RH103315"
                     /db_xref="UniSTS:97646"
     STS             1540..2358
                     /gene="CAB39L"
                     /gene_synonym="bA103J18.3; MO25-BETA; MO2L; RP11-103J18.3"
                     /standard_name="CAB39L__4492"
                     /db_xref="UniSTS:471378"
     STS             2132..2291
                     /gene="CAB39L"
                     /gene_synonym="bA103J18.3; MO25-BETA; MO2L; RP11-103J18.3"
                     /standard_name="RH91905"
                     /db_xref="UniSTS:87826"
     polyA_signal    2350..2355
                     /gene="CAB39L"
                     /gene_synonym="bA103J18.3; MO25-BETA; MO2L; RP11-103J18.3"
     polyA_site      2374
                     /gene="CAB39L"
                     /gene_synonym="bA103J18.3; MO25-BETA; MO2L; RP11-103J18.3"
     STS             3289..3416
                     /gene="CAB39L"
                     /gene_synonym="bA103J18.3; MO25-BETA; MO2L; RP11-103J18.3"
                     /standard_name="STS-N23383"
                     /db_xref="UniSTS:57953"
ORIGIN      
agcgctctcggcttgtctcgcgcactgtagctgagccaatggagttactcgtagtcgagaggccggcatcactggagtggtggcgcagctgtttcctccggatatccatcaaatattgagaagaaagaatatcaggagcaaagtgttctaagttgctgttcagaacgtaaagatgcgaaccccaaatcagtggtttgttcattcttcatgcaagagcaatgcactaaaggagagaagcaagctgtggtgatcagtgactttggtgaaagctaagaaggttcaaacaaatttgcaaatgatatacaacttctaagcattccatattggaagaagagatttctacacatgaaaaaaatgcctttgtttagtaaatcacacaaaaatccagcagaaattgtgaaaatcctgaaagacaatttggccattttggaaaagcaagacaaaaagacagacaaggcttcagaagaagtgtctaaatcactgcaagcaatgaaagaaattctgtgtggtacaaacgagaaagaacccccaacagaagcagtggctcagctagcacaagaactctacagcagtggcctgctagtgacactgatagctgacctgcagctgatagactttgagggaaaaaaagatgtgacccagatatttaacaacatcttgagaagacagataggcactcggagtcctactgtggagtatattagtgctcatcctcatatcctgtttatgctcctcaaaggatatgaagccccacagattgccttacgttgtgggattatgctgagagaatgtattcgacatgaaccacttgccaaaatcatcctcttttctaatcaattcagagatttctttaagtacgtggagttgtcaacatttgatattgcttcagatgcctttgctactttcaaggatttactaaccagacataaagtgttggtagcagacttcttagaacaaaattacgacactatttttgaagactatgagaaattgcttcagtctgagaattatgttactaagagacagtctttaaagctgctaggggagctgatcctggaccgtcacaactttgccatcatgacaaagtatatcagcaagccggagaacctgaaactcatgatgaacctccttcgggataaaagtcccaacatccagtttgaagcctttcatgtttttaaggtgtttgtggccagtcctcacaaaacacagcctattgtggagatcctgttaaaaaatcagcccaaactcattgagtttctgagcagcttccaaaaagaaaggacggatgatgagcagttcgctgacgagaagaactacttgattaaacagatccgagacttgaagaaaacggccccttgaagagctccccggcccctgtcacagtcagtcgtctcatttgtccagtttgtacagtgtgtcatttcagaaagtcatcattcttgggaagactttggaggtgcctattttttctgctgtaattgttctgggtagatggagtataaacatttgaatggaaaaaaattaacctagaataatatattcattttagtcaagtctgtgattatttatgtgaaatgagaaccattgtatcagatgttgataaaagcaattttaacttgcagatgtgagcccctgggcacaatgagccgctaaatgggagctcaattgacaggcatcaccaagtcttcaaggaggactgagttctcaggggagaactgggaatggggccagggtgcaaaaatgctttgcccatctgtaggtagacacacagatcgctcagggcactgagagatcccagaaggtaacgttaatgttttcagtcattgtgtgtcctttgttgctgccaatgtctttggactgtaatcagtgcatccacacctcccaggatccagtgctccctctcagctcagtctcccctctctccctgtcctgcattccatcccagctcctcagcatggcctcagtgggcgcacccatgcctcccgcagtccaggtgagcaggggagcaactgagcaggaagaggatggatcaacaagggtcacggggaataggggacccacggggtgtgacctgcttgctagagaactgtgaacatgtggctctggatagagtgactgctgctccatattagcttccagagggtgagtgagggacagaatatttccttcataatggtcatgggtgaatgctttctgctgtaagtgtcttttagagtaggaatcagcatagtgggatgcccagcaggcacaaaccatgggtccagggagtctcagcggggaacttctatcagtatcaataaccattggaaggagaaatgattcatgtgtgaaaaaattctcagatccatcaataaatttttttcagagccattgtatcagatgttgataaaagcaatttttttctaataagctgtcattctataattgcccatcacagtctttagtgaacacatagaaagcctatacagttttggtcctgaatagtctcttgtgactaggatgattgaggtgttaattcctcttccttataaaaaggcttggaatcaaaaatattttaaaaggccgtggtttcgtttcagacatcaaccatctaaaacgggattttaaagcgatattttacaagaatgaaaggcacaattgttgatctgtattttttacacttcagtttctaaatcatgaatcgttgccttccacaggaaccctcccttatacattacttgagtgttgtgtagtttttcttcagccaggtatttctctgcctagagaggggaagagaaatgtgttctccaggactgatcccctttgtagattttgtacctgaagagttacctggcagggcaccacccttggctaggcccaggtgtgtgtttctttcttgcctggcatggaccccgaggcaggtgatgtggggcctggcgcacctccccgctttggcagctgtggcctccctggccagtgcccttgcaggaggccggccggcagcctgatgacccgtactctttagtcactgacgtcagattatttttataacgttccctgacagttcagagtcccttcgaattgcacttttctggtttcgcttatttaattaaaagagatgagtgtaagtataaaaaatgaaggtgaaataaccattggaattgtatttggttacttaatactgttccacaacatcttgggacgtctgttttcctttggagagtgaggccttgttattattcttttctgataaagaaaacattttatttcctttgggcttgcattagctctttcctagcaacccattatcccagctcagtacctttcaaacagaaaactagagtctggggttttgttgtgatctgaatttgtaagttattaatgtgaaagggggagcaggaagctccccctttgcacaaagggggatttgtttgcacaaagttcactgtaaatactgtgagaattgaattctgaaaaggtcatatttagtgatttcaaaagcacacatttaaatgaagactgactaaataaaaggtaccacacaaaaaaaaaaaaaaaa
//

Annotations:

ANNOTATIONS from NCBI Entrez Gene (20130726):
            GeneID:81617 -> Biological process: GO:0007050 [cell cycle arrest] evidence: TAS
            GeneID:81617 -> Biological process: GO:0008286 [insulin receptor signaling pathway] evidence: TAS
            GeneID:81617 -> Cellular component: GO:0005829 [cytosol] evidence: TAS

by @meso_cacase at DBCLS
This page is licensed under a Creative Commons Attribution 2.1 Japan License.